Pretreatment with frequent topical betamethasone in Ahmed glaucoma valve implantation

To evaluate the efficacy of pretreatment with topical betamethasone in Ahmed glaucoma valve (AGV) implantation. Randomized clinical trial. Sixty-two eyes from 62 patients undergoing AGV. We randomly assigned patients undergoing AGV to 2 arms of the study. The case group received AGV implantation wit...

Full description

Saved in:
Bibliographic Details
Published in:Canadian journal of ophthalmology 2022-08, Vol.57 (4), p.270-276
Main Authors: Yadgari, Maryam, Vafaei, Fatemeh, Sobhani, Soheila, Sheibani, Kourosh, Noorizadeh, Farsad
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate the efficacy of pretreatment with topical betamethasone in Ahmed glaucoma valve (AGV) implantation. Randomized clinical trial. Sixty-two eyes from 62 patients undergoing AGV. We randomly assigned patients undergoing AGV to 2 arms of the study. The case group received AGV implantation with preoperative betamethasone eye drops, and the control group did not receive preoperative betamethasone. Follow-up examinations were performed on postoperative day 1, at least weekly for 4 weeks, and then every 1 to 3 months. Our main outcome measure was the rate of success, defined as intraocular pressure (IOP)
ISSN:0008-4182
1715-3360
DOI:10.1016/j.jcjo.2021.04.016